secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2023-10-20T23:59:59+00:00
Accession:  0001493152-23-037907
Event type: other_material
Sentiment:  negative
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma announces unexpected death of director Dr. Franklyn Prendergast
------------------------------------------------------------------------------

- Dr. Franklyn Prendergast died unexpectedly; company learned on October 17, 2023.
- Prendergast had served as a director of Lantern Pharma since October 2019.
- No replacement or board succession plan disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223037907/0001493152-23-037907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315223037907/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer